Minerva Neurosciences Appoints New Chief Accounting Officer

What Happened
Minerva Neurosciences (NERV) filed an 8-K (Item 5.02) reporting that on August 10, 2026 the Board appointed Anthony Aliquo as the Company’s Chief Accounting Officer and principal accounting officer, effective that date. Fred Ahlholm ceased to be the principal accounting officer on the same date but will remain the Company’s Chief Financial Officer and principal financial officer.

Key Details

• Appointment effective August 10, 2026; change reported on Form 8-K under Item 5.02.
• Mr. Aliquo (age 39) is a CPA with prior roles at Minerva: VP, Controller (Nov 2022–Jul 2026); Controller (Aug 2021–Nov 2022); Assistant Controller (Sep 2020–Aug 2021). He previously worked as an auditor at BDO USA and Deloitte & Touche.
• The Board approved an increase in Mr. Aliquo’s annual base salary to $296,696 effective July 1, 2026, and raised his annual performance bonus target to 35% of base salary. Other compensation terms remain unchanged.
• The filing states there are no related-party arrangements or family relationships requiring disclosure under Item 404(a) of Regulation S‑K.

Why It Matters
A change in the principal accounting officer affects who is responsible for the company’s accounting and financial reporting oversight. Investors should note the CFO (Fred Ahlholm) remains in place as principal financial officer, so financial leadership continuity is retained. The promotion and pay adjustments indicate Minerva is formalizing its accounting leadership internally; there are no disclosed related-party issues or unusual arrangements tied to the appointment.